Table of Contents
ISRN Pharmaceutics
Volume 2013, Article ID 378452, 14 pages
http://dx.doi.org/10.1155/2013/378452
Research Article

-DTPA-Meglumine-Anionic Linear Globular Dendrimer G1: Novel Nanosized Low Toxic Tumor Molecular MR Imaging Agent

1Department of Biological Science, School of Science, Science and Research Branch, Islamic Azad University, Tehran 14515-775, Iran
2Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, Iran
3Medical Physics and Biomedical Engineering and Nanomedicine Department, Faculty of Medicine, Shahid Beheshti Medical University, Tehran 1985717443, Iran
4Department of Nanobiotechnology, Hepatitis and AIDS, Pasteur Institute of Iran, Tehran 1316943551, Iran
5Department of Radiopharmacy and Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614411, Iran

Received 21 October 2012; Accepted 18 December 2012

Academic Editors: J.-J. Chen and J. V. de Julián-Ortiz

Copyright © 2013 Tahmineh Darvish Mohamadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Amanlou, S. D. Siadat, S. E. S. Ebrahimi et al., “Gd3+-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent,” International Journal of Nanomedicine, vol. 6, pp. 747–763, 2011. View at Publisher · View at Google Scholar
  2. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA: A Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Fass, “Imaging and cancer: a review,” Molecular Oncology, vol. 2, no. 2, pp. 115–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Weishaupt, V. D. Köchli, and B. Marincek, “Spin and the nuclear magnetic resonance phenomenon,” in How Dose MRI Work? An Introduction to the Physics and Function of the Magnetic Resonance Imaging, pp. 1–8, Springer, Berlin, Germany, 2003. View at Google Scholar
  6. J. M. Reddy and V. Prasad, “MRI contrast agent,” in Step by Step MRI, pp. 124–132, Jaypee Brothers Medical Publishers, New Delhi, India, 2005. View at Google Scholar
  7. A. Earnshaw and N. Greenwood, “The lanthanide elements,” in Chemistry of Elements, pp. 1227–1249, Elsevier Science, Burlington, Mass, USA, 1984. View at Google Scholar
  8. H. A. Goldstein, F. K. Kashanian, R. F. Blumetti, W. L. Holyoak, F. P. Hugo, and D. M. Blumenfield, “Safety assessment of gadopentetate dimeglumine in U.S. clinical trials,” Radiology, vol. 174, no. 1, pp. 17–23, 1990. View at Google Scholar · View at Scopus
  9. R. A. Freitas Jr., “What is nanomedicine?” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 1, no. 1, pp. 2–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Klajnert and M. Bryszewska, “Dendrimers: properties and applications,” Acta Biochimica Polonica, vol. 48, no. 1, pp. 199–208, 2001. View at Google Scholar · View at Scopus
  11. P. Antoni, Y. Hed, A. Nordberg et al., “Bifunctional dendrimers: from robust synthesis and accelerated one-pot postfunctionalization strategy to potential applications,” Angewandte Chemie, vol. 48, no. 12, pp. 2126–2130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Jain, P. Kesharwani, U. Gupta, and N. K. Jain, “Dendrimer toxicity: let's meet the challenge,” International Journal of Pharmaceutics, vol. 394, no. 1-2, pp. 122–142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Namazi and M. Adeli, “Novel linear-globular thermoreversible hydrogel ABA type copolymers from dendritic citric acid as the A blocks and poly(ethyleneglycol) as the B block,” European Polymer Journal, vol. 39, no. 7, pp. 1491–1500, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Steger-Hartmann, R. Hofmeister, R. Ernst, H. Pietsch, M. A. Sieber, and J. Walter, “A review of preclinical safety data for magnevist (gadopentetate dimeglumine) in the context of nephrogenic systemic fibrosis,” Investigative Radiology, vol. 45, no. 9, pp. 520–528, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Wong, J. S. Ananta, S. lin, and L. J. Wilson, “In vitro relaxivities studies of gadolinium carbon nanotubes at 3T,” The International Society for Magnetic Resonance in Medicine, vol. 16, p. 1665, 2008. View at Google Scholar
  16. A. D'Emanuele and D. Attwood, “Dendrimer-drug interactions,” Advanced Drug Delivery Reviews, vol. 57, no. 15, pp. 2147–2162, 2005. View at Publisher · View at Google Scholar · View at Scopus